Ultragenyx Pharmaceutical Inc.

0LIF•London Stock Exchange

United Kingdom

Need professional-grade analysis? Visit stockanalysis.com

£24.03

-3.31%

End of day

Market Cap

$1.45B

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	-2.50	76.92	0.60	-0.66	-0.52	—	9.86
Calmar	-18.90	—	0.94	-0.98	-0.60	—	-1.77
Sharpe	-2.79	37.08	0.42	-0.56	-0.44	—	4.55
Omega	0.13	3.09	1.12	0.94	0.97	—	1.22
Martin	-32.66	—	2.09	-1.56	-1.06	—	-2.92
Ulcer	2.84	1.92	10.78	30.86	30.77	—	21.09

Also Listed On

RARE.US

United States · USD

$1.79B

Ultragenyx Pharmaceutical Inc. (0LIF) Price Performance

Ultragenyx Pharmaceutical Inc. (0LIF) trades on London Stock Exchange in GBP. The stock currently trades at GBP24.03, down 3.31% from the previous close.

Over the past year, 0LIF has traded between a low of GBP18.82 and a high of GBP41.20. The stock has lost 34.7% over this period. It is currently 41.7% below its 52-week high.

Ultragenyx Pharmaceutical Inc. has a market capitalization of $1.45B.

Company Info

Sector: N/A
Industry: N/A
Exchange: London Stock Exchange
Currency: GBP
Country: United Kingdom

Financial Metrics

Revenue (TTM): $673.00M
EBITDA: $-500,000,000
Profit Margin: -85.44%
EPS (TTM): -6.87
Book Value: -0.83

Technical Indicators

52 Week High: £42.00
52 Week Low: £18.00
50 Day MA: £22.43
200 Day MA: £28.50
Beta: 0.25

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: 2.15
Price/Book: -29.94
Enterprise Value: $2.98B